Artivion, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting a net loss of $7.926 million for the third quarter and disclosing the acquisition of Endospan during the nine-month period.
Key Highlights
- Q3 2026 net loss: Artivion reported a net loss of $7,926 thousand for the three months ended September 30, 2026, compared to net income of $6,502 thousand in the same period of 2025.
- Q3 total revenues: Total revenues reached $123,790 thousand for the third quarter of 2026, up from $113,388 thousand in Q3 2025.
- Nine-month net loss: For the nine months ended September 30, 2026, the company reported a net loss of $20,019 thousand, versus net income of $7,342 thousand in the comparable 2025 period.
- Endospan acquisition: The company paid $116,661 thousand, net of cash acquired, for the acquisition of Endospan during the nine months ended September 30, 2026.
- Total assets: Total assets were $1,042,088 thousand as of September 30, 2026, compared to $884,796 thousand as of December 31, 2025.
- Long-term debt increase: Long-term debt, net rose to $363,787 thousand as of September 30, 2026 from $215,114 thousand at December 31, 2025, following proceeds from issuance of long-term debt of $148,875 thousand in the nine-month period.
- Shares outstanding: Common shares outstanding were 48,789,772 as of October 30, 2026.
Artivion's Q3 2026 Financial Results and Endospan Acquisition Impact
According to the filing, Artivion, Inc. (NYSE:AORT) reported total revenues of $123,790 thousand for the three months ended September 30, 2026, consisting of $98,160 thousand in product revenues and $25,630 thousand in preservation services revenues. Gross margin for the quarter was $75,977 thousand. Operating income declined to $2,947 thousand from $12,536 thousand in Q3 2025, as general, administrative, and marketing expenses rose to $63,222 thousand from $57,281 thousand, and research and development costs increased to $9,808 thousand from $8,078 thousand in the prior-year quarter.
The company disclosed interest expense of $8,518 thousand for Q3 2026, up from $6,119 thousand in Q3 2025, contributing to a pre-tax loss of $5,920 thousand. After income tax expense of $2,006 thousand, the net loss for the quarter was $7,926 thousand, or $(0.16) per basic and diluted share. For the nine months ended September 30, 2026, total revenues were $365,884 thousand and the net loss was $20,019 thousand, or $(0.41) per basic and diluted share.
The condensed consolidated balance sheet reflected the impact of the Endospan acquisition. Goodwill rose to $344,961 thousand at September 30, 2026 from $254,091 thousand at December 31, 2025, and acquired technology, net increased to $145,901 thousand from $123,664 thousand. The acquisition was funded in part through the issuance of long-term debt; the company reported proceeds from issuance of long-term debt, net of $148,875 thousand during the nine months ended September 30, 2026. Operating cash flows were negative at $(4,668) thousand for the nine-month period, compared to positive $20,320 thousand in the prior-year period. Total stockholders' equity was $446,400 thousand as of September 30, 2026.
What Was Disclosed
Artivion filed its quarterly report covering the period ended September 30, 2026, disclosing a third-quarter net loss of $7,926 thousand, revenue growth to $123,790 thousand, the closing of the Endospan acquisition for $116,661 thousand net of cash, and a significant increase in long-term debt and total assets.



Please wait processing your request...